Terumo Sustainability Profile
Terumo Corporation, a leading global medical technology company headquartered in Japan, has been at the forefront of healthcare innovation since its founding in 1921. With a strong presence in regions such as Europe, Asia, and the Americas, Terumo operates primarily within the medical devices industry, focusing on areas like vascular intervention, blood management, and surgical products. Renowned for its commitment to quality and safety, Terumo offers a diverse range of core products, including advanced catheter systems, blood collection devices, and infusion systems. These products are distinguished by their cutting-edge technology and user-centric design, ensuring optimal performance in clinical settings. As a trusted partner in healthcare, Terumo has achieved significant milestones, including numerous certifications and recognitions for excellence in medical technology, solidifying its position as a key player in the global market.
DitchCarbon Score
How does Terumo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Terumo's score of 60 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Terumo's reported carbon emissions
In 2024, Terumo Corporation reported total carbon emissions of approximately 2,562,700 kg CO2e in Great Britain, with emissions distributed across various scopes: 1,015,800 kg CO2e from Scope 1, 1,191,800 kg CO2e from Scope 2, and 1,345,100 kg CO2e from Scope 3. Notably, Scope 3 emissions included significant contributions from business travel (approximately 853,900 kg CO2e), employee commuting (approximately 636,000 kg CO2e), and upstream transportation and distribution (approximately 994,000 kg CO2e). Terumo has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50.4% by 2030 from a 2018 baseline. Additionally, the company targets a 60% reduction in Scope 3 emissions per unit of revenue over the same timeframe. Long-term goals include achieving carbon neutrality by 2040 for both Scope 1 and Scope 2 emissions. These targets align with the Science Based Targets initiative (SBTi) and reflect Terumo's commitment to sustainable practices within the healthcare equipment and supplies sector. The company is actively working towards these goals, demonstrating a proactive approach to mitigating climate impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2005 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Terumo's Industry?
How Carbon Intensive is Terumo's Location?
Terumo's Scope 3 Categories Breakdown
Terumo's Scope 3 emissions, which decreased by 0% last year and increased by approximately 16% since 2018, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 61% of Scope 3 emissions.
Top Scope 3 Categories
Terumo's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Terumo has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Applied Medical Resources Corporation
Smith Plus Nephew
Frequently Asked Questions
Common questions about Terumo's sustainability data and climate commitments